Vascular Diseases Affect Millions; Innovative Treatments Are Still Needed
Introducing BioGenCell’s revolutionary cell therapy, harnessing cell therapy to provide a simple and accessible solution to the needs of patients and the healthcare community.
Vascular diseases can cause conditions such as peripheral vascular disease, heart disease, stroke, and blindness, and account for 25% of global death cases.
High Treatments Costs
The cost of treating microvascular diseases places a significant financial burden on patients, institutions and payers, amounting to billions of dollars each year.
No-Option Patients
Despite major advancements in science and medicine, healthcare providers are still looking for solutions for patients who don’t respond to traditional treatments.
Personalized Treatments in 3 Steps
In three steps, we make personalized cell therapy available for everyone. We do so by mimicking, externally, the natural processes of the body enabling cells to flourish outside their natural environment.
Blood collection
Processing
Treatment
The BioGenCell TRACT Leap
Our TRACT platform uses innovative bio technology to turn a patients own blood into a mass-produced treatment. BioGenCell is able to produce the treatment in one day, and apply it in a single appointment.
1 Day
Production
Single
Treatment
Lasting
Effect
Clinical Advantages: Safe and Accessible Treatments
No Preconditioning
No Genetic Modification
No Risk of Rejection
Anti-inflammatory (pro-tolerance)
Pro-angiogenic
Supporting vasculogenesis & neovascularization
The Science Behind BioGenCell
We harness the alternative activation pathways to modulate stem/progenitor cell-specific activity
This Product line implements the company’s technology for treating blood vessel insufficiency that causes multiple organ failure in the elderly and diabetic patient populations.
This Product line implements the company’s technology for treating blood vessel insufficiency that causes multiple organ failure in the elderly and diabetic patient populations.
Starting with BGC10X for Microvascular Diseases, BioGenCell’s pipeline shows great potential for treating a range of degenerative diseases. Our cutting-edge research and development team is working tirelessly to bring more innovative therapies to market.
We may use cookies to enhance your browsing experience, and analyze usage in the Website.